Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation (Q82155725)
Jump to navigation
Jump to search
scientific article published on 21 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation |
scientific article published on 21 October 2011 |
Statements
Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation (English)
A Dieckmann
M Kriebel
E Andriambeloson
D Ziegler
21 October 2011